Yufeng Yang

Yufeng Yang

Auto-generated profile, based on publicly available information

Yufeng Yang


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2023 in Frontiers in Nutrition
Verified
Journal Article
Open access
XYXinrui Yi
Xinrui Yi
MDMosi Dong
Mosi Dong
NGNaifei Guo
Naifei Guo
JTJinlong Tian
Jinlong Tian
PLPing Lei
Ping Lei
YSYan Shi
Yan Shi
The prevalence of type 2 diabetes mellitus (T2DM) is increasing every year. Medications are currently the most common therapy for T2DM. However, these medications have certain adverse effects. In order to find safe and effective ways to improve this disease, researchers have discovered that some natural products can decrease blood sugar. Flavonoids are one of the most essential low molecular weight phenolic chemicals in the plant world, which widely exist in plant roots, stems, leaves, flowers, and fruits. They possess a variety of biological activities, including organ protection, hypoglycemic, lipid-lowering, anti-oxidative and anti-inflammatory effects. Some natural flavonoids ameliorate T2DM and its complications through anti-oxidation, anti-inflammatory action, glucose and lipid metabolism regulation, insulin resistance management, etc. Hence, this review aims at demonstrating the potential benefits of flavonoids in T2DM and its complications. This laid the foundation for the development of novel hypoglycemic medications from flavonoids.

26 August 2024 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
XLXinxin Luo
Xinxin Luo
MDMosi Dong
Mosi Dong
JLJuntong Liu
Juntong Liu
NGNaifei Guo
Naifei Guo
JLJing Li
Jing Li
YYYufeng Yang
Yufeng Yang
Fermentation is an important concoction technique for botanical drugs. Fermentation transforms and enhances the active ingredients of botanical drugs through specific microbiological processes, ultimately affecting their pharmacological effects. This review explores the use of fermented botanical drugs in areas such as anti-tumor, hypolipidemic, antioxidant, antimicrobial, cosmetology, and intestinal flora regulation. It elucidates the potential pharmacological mechanisms and discusses the benefits of fermentation technology for botanical drugs, including reducing toxic side effects, enhancing drug efficacy, and creating new active ingredients. This article also discussesdelves into the common strains and factors influencing the fermentation process, which are crucial for the successful transformation and enhancement of these drugs. Taken together, this study aimed to provide a reference point for further research and wider applications of botanical drug fermentation technology.

12 April 2022 in Frontiers in Genetics
Verified
Journal Article
Open access
TMTongyu Meng
Tongyu Meng
QWQingfeng Wang
Qingfeng Wang
YYYufeng Yang&Ast
Yufeng Yang&Ast
YRYanling Ren
Yanling Ren
YSYan Shi
Yan Shi
Background: Many miRNAs have been demonstrated to be associated with the prognosis of hepatocellular carcinoma (HCC). However, how to combine necroptosis-related miRNAs to achieve the best predictive effect in estimating HCC patient survival has not been explored.Methods: The mRNA and miRNA expression profile were downloaded from a public database (TCGA-LIHC cohort). Necroptosis-related genes were obtained from previous references, and necroptosis-related miRNAs were identified using Pearson analysis. Subsequently, differential expression miRNAs (DEms) were identified in HCC and paracancer normal samples based on necroptosis-related miRNA expression. The whole set with HCC was randomized into a training set and testing set (1:1). LASSO-Cox regression analysis was used to construct an miRNA signature. Multiple statistical methods were used to validate the clinical benefit of signature in HCC patients, including receiver operator characteristic (ROC) curves, Kaplan–Meier survival analyses, and decision curve analysis (DCA). The downstream target genes of miRNAs were obtained from different online tools, and the potential pathways involved in miRNAs were explored. Finally, we conducted RT-qPCR in SK-HEP-1, THLE-3, and HUH-7 cell lines for miRNAs involved in the signature.Results: The results showed that a total of eight specific necroptosis-related miRNAs were screened between HCC and adjacent tissues in the training set. Subsequently, based on the aforementioned miRNAs, 5-miRNA signature (miR-139-5p, hsa-miR-326, miR-10b-5p, miR-500a-3p, and miR-592) was generated by LASSO-Cox regression analysis. Multivariate Cox regression analysis showed that the risk scores were independent prognostic indicators in each set. The area under curves (AUCs) of 1 year, 3 years, 5 years, and 7 years were high in each set (AUC >0.7). DCA analysis also revealed that the risk score had a potential benefit than other clinical characteristics. Meanwhile, survival analysis showed that the high-risk group showed low survival probabilities. Moreover, the results of enrichment analysis showed that specific miRNAs were mainly enriched in the cAMP signaling pathway and TNF signaling pathway. Finally, the results of RT-qPCR were consistent with the prediction results in public databases.Conclusion: Our study establishes a robust tool based on 5-necroptosis-related miRNAs for the prognostic management of HCC patients.

14 July 2022 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
XLXiangnan Li
Xiangnan Li
WCWenna Chen
Wenna Chen
LMLanying Miao
Lanying Miao
HSHongwei Sun
Hongwei Sun
XGXia Gao
Xia Gao
JGJunfu Guo
Junfu Guo
The Si-Jun-Zi decoction (SJZ), a traditional Chinese medicine (TCM) formula, is used clinically against multiple malignancies, including gastric cancer (GC). In previous study, we have shown that SJZ plays an anticancer role in SGC7901 cell xenograft mice models. However, the underlying mechanisms are unclear. The objective of this study was to evaluate the effect and mechanism of SJZ on the proliferation, migration, invasion, and cancer stem cell-like properties of GC cells. High-throughput mRNA sequencing analysis was performed to investigate the global alterations in gene expression in xenograft tumors, and 56 significantly differentially expressed genes (43 upregulated and 13 downregulated genes) were identified between the SJZ group and the Model group totally. We focused on CMTM2, which was significantly increased after SJZ intervention, as a candidate target gene of SJZ. The results indicated that CMTM2 expression was elevated in SJZ-treated SGC7901 cells and knocking-down CMTM2 expression partially hampered the inhibitory effects of SJZ on the proliferation, migration, and invasion of GC cells. Moreover, SJZ treatment repressed the spheroid and colony-forming capacity in GC cells, accompanied by downregulation of stem cell markers including SOX2, NANOG, and CD44. CMTM2 knockdown antagonized the effects of SJZ on the cancer stem cell-like properties of SGC7901 cells. Thus, SJZ effectively suppressed the proliferation, migration, invasion, and cancer stem cell-like properties of GC cells in vitro by upregulating CMTM2 expression.

27 November 2025 in Food Science & Nutrition
Verified
Journal Article
Open access
MWMeizi Wang
Meizi Wang
WLWeizhong Li
Weizhong Li
QCQiong Cheng
Qiong Cheng
JSJiayu Sun
Jiayu Sun
CCCheng Cheng
Cheng Cheng
YYYufeng Yang
Yufeng Yang
The growing demand for functional foods derived from medicinal‐edible homologous resources offers a promising strategy to address the chronic metabolic dysregulation underlying diabetic kidney disease (DKD), particularly in patients requiring long‐term pharmacological interventions. DKD, a metabolic disorder‐driven complication of diabetes, is characterized by chronic hyperglycemia, insulin resistance (IR), and systemic metabolic dysregulation, necessitating novel dietary approaches to complement conventional therapies. To systematically explore the therapeutic potential of medicinal‐edible homologous herbs in DKD management, this study retrieved clinical literature from the China National Knowledge Infrastructure (CNKI) database, focusing on traditional Chinese medicines (CHMs) with dual dietary and therapeutic functions. By integrating data mining techniques (frequency analysis, attribute‐flavor analysis, herb‐pair co‐occurrence networks, and cluster analysis) with expert clinical consensus, we prioritized the identification of core medicinal‐edible homologous combinations that align with DKD's metabolic pathology. This multi‐dimensional approach revealed Huangqi ( Astragali Radix ), Fuling ( Poria ), and Dahuang ( Rhei Radix et Rhizoma ) (Ast‐Por‐Rhe) as the most predictive herb combination, highlighting their synergistic role as functional food‐derived agents in mitigating DKD progression. Network pharmacology revealed that Ast‐Por‐Rhe's bioactive components (e.g., isorhamnetin, 7‐O‐methyleriodictyol) act as dual‐purpose nutrients and metabolic regulators, synergistically targeting 38 DKD‐associated genes. Functional enrichment analysis demonstrated Ast‐Por‐Rhe's capacity to restore metabolic homeostasis by alleviating IR through dephosphorylation modulation, while rectifying PI3K‐Akt signaling. In a streptozotocin (STZ)‐induced DKD rat model, Ast‐Por‐Rhe supplementation, as a functional food intervention, significantly mitigated renal metabolic dysfunction, evidenced by enhanced IRS1/PI3K/Akt activity, reduced lipid peroxidation, and improved renal fibrosis. These findings position Ast‐Por‐Rhe as a paradigm of medicinal‐edible homologous functional foods that counteract DKD progression through multi‐component synergy, specifically targeting IR‐driven metabolic perturbations. This study provides a translational roadmap for developing evidence‐based dietary strategies using bioactive food components, advancing the application of medicinal‐edible resources in metabolic disorder management.

26 January 2026 in The American Journal of Chinese Medicine
Verified
Journal Article
Closed access
RYRuodi Yang
Ruodi Yang
YZYing Zhou
Ying Zhou
YSYuhang Shen
Yuhang Shen
JLJuntong Liu
Juntong Liu
YSYan Shi
Yan Shi
YYYufeng Yang
Yufeng Yang